Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma
- PMID: 28005257
- DOI: 10.1007/s12020-016-1214-0
Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma
Abstract
Purpose: Patients affected by Cushing's disease often have important comorbidities directly linked to hypercortisolism that might enhance the operative risk. We report the safety of transsphenoidal surgery in patients affected by Cushing's disease as compared with patients with nonfunctioning pituitary adenoma.
Methods: We have retrospectively analyzed 142 patients with Cushing's disease and 299 patients with nonfunctioning pituitary adenoma who underwent transsphenoidal surgery performed by a single experienced neurosurgeon between September 2007 and December 2014. For all of them, an intraoperative computerized anesthetic record for the automatic storage of data was available.
Results: The intraoperative vital parameters and the frequency of drugs administered during anesthesia were comparable between Cushing's disease and nonfunctioning pituitary adenoma groups. The duration of surgery was similar between the two groups (41.2 ± 11.8 vs. 42.9 ± 15.6 min), while the duration of anesthesia was slightly shorter in Cushing's disease patients (97.6 ± 18.1 min) than in nonfunctioning pituitary adenoma patients (101.6 ± 20.6 min, p = 0.04). The total perioperative mortality rate was 0.2% (0% in Cushing's disease vs. 0.3% in nonfunctioning pituitary adenoma). Cushing's disease patients had surgical and medical complication rates of 3.5% each, not different from those occurring in nonfunctioning pituitary adenoma. The postoperative incidence of diabetes insipidus (10.6%) and isolated hyponatremia (10.6%) in Cushing's disease patients was significantly higher than in nonfunctioning pituitary adenoma patients (4.4 and 4.1%; p = 0.02 and p = 0.01, respectively).
Conclusions: In a large series of unselected and consecutive patients with Cushing's disease, transsphenoidal surgery performed by one dedicated experienced neurosurgeon had a reasonably low risk of complications. In particular, despite the higher burden of comorbidities typically associated with hypercortisolism, medical complications are rare and no more frequent than in patients with nonfunctioning pituitary adenoma.
Keywords: Anesthesia; Cushing’s disease; Intraoperative monitoring; Pituitary neoplasm; Pituitary surgery.
Similar articles
-
Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.Neurosurg Focus. 2015 Feb;38(2):E12. doi: 10.3171/2014.10.FOCUS14705. Neurosurg Focus. 2015. PMID: 25639314
-
National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.Neurosurg Focus. 2007;23(3):E7. doi: 10.3171/foc.2007.23.3.9. Neurosurg Focus. 2007. PMID: 17961019
-
A pitfall in diagnosing Cushing's disease: ectopic ACTH-producing pituitary adenoma in the sphenoid sinus.Pituitary. 2015 Apr;18(2):279-82. doi: 10.1007/s11102-014-0591-8. Pituitary. 2015. PMID: 25129688
-
Efficacy of endoscopic transsphenoidal surgery for cushing's disease: Case series and review of the literature.Neurol India. 2020 Mar-Apr;68(2):403-406. doi: 10.4103/0028-3886.284363. Neurol India. 2020. PMID: 32415015 Review.
-
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901. J Neurosurg. 2018. PMID: 29219752 Review.
Cited by
-
Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.Acta Neurochir (Wien). 2021 Nov;163(11):3161-3169. doi: 10.1007/s00701-021-04830-2. Epub 2021 Apr 3. Acta Neurochir (Wien). 2021. PMID: 33811521 Free PMC article.
-
Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.Pituitary. 2018 Feb;21(1):98-106. doi: 10.1007/s11102-017-0842-6. Pituitary. 2018. PMID: 29027644
-
Pituitary Adenomas: From Diagnosis to Therapeutics.Biomedicines. 2021 Apr 30;9(5):494. doi: 10.3390/biomedicines9050494. Biomedicines. 2021. PMID: 33946142 Free PMC article. Review.
-
Pretreatment with somatostatin analogs does not affect the anesthesiologic management of patients with acromegaly.Pituitary. 2019 Apr;22(2):187-194. doi: 10.1007/s11102-019-00952-0. Pituitary. 2019. PMID: 30826981
-
Specific focus on the basal dura for improving Cushing's disease surgery: a cohort study.Neurosurg Rev. 2025 Jun 5;48(1):483. doi: 10.1007/s10143-025-03656-1. Neurosurg Rev. 2025. PMID: 40471392
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources